Determining Toxoplasma high-risk autologous and allogeneic hematopoietic stem cell transplantation patients by systematic pre-transplant PCR screening of stem cell originated buffy coat

Parasitology International

Volumn 61, Issue 4, 2012, Pages 565-571

  Caner, Ayşe ^a,b   Dönmez, Ayhan ^a   Döşkaya, Mert ^a   Deǧirmenci, Aysu ^a   Tombuloǧlu, Murat ^a   Çaǧirgan, Seçkin ^a   Guy, Edward ^b   Francis, Janet ^b   Soyer, Nur Akad ^a   Gürüz, Yüksel ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SINGLETON HOSPITAL   (United Kingdom)

Author keywords

Allogeneic; Autologous; Buffy coat PCR; Hematopoietic stem cell transplantation; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD SAMPLING; BONE MARROW BUFFY COAT; CLINICAL ARTICLE; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; TOXOPLASMOSIS;

ADULT; AGED; ANIMALS; BLOOD BUFFY COAT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 84865979758     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2012.05.005     Document Type: Article

References (40)

1. Chandrasekar P.H., Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. The Bone Marrow Transplant Team. Bone Marrow Transplantation 1997, 19:685-689.
2. Cibickova L., Horacek J., Prasil P., Slovacek L., Kohout A., Cerovsky V., et al. Cerebral toxoplasmosis in an allogeneic peripheral stem cell transplant recipient: case report and review of literature. Transplant Infectious Disease 2007, 9:332-335.
3. Derouin F., Gluckman E., Beauvais B., Devergie A., Melo R., Monny M., et al. Toxoplasma infection after human allogeneic bone marrow transplantation: clinical and serological study of 80 patients. Bone Marrow Transplantation 1986, 1:67-73.
4. Derouin F., Pelloux H. Prevention of toxoplasmosis in transplant patients. Clinical Microbiology and Infection 2008, 14:1089-1101. ESCMID Study Group on Clinical Parasitology.
5. González M.I., Caballero D., Lopez C., Alburquerque T., Hernández R., de la Loma A., et al. Cerebral toxoplasmosis and Guillain-Barré syndrome after allogeneic peripheral stem cell transplantation. Transplant Infectious Disease 2000, 2:145-149.
6. Martino R., Maertens J., Bretagne S., Rovira M., Deconinck E., Ullmann A.J., et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clinical Infectious Diseases 2000, 31:1188-1195.
7. Fricker-Hidalgo H., Bulabois C.E., Brenier-Pinchart M.P., Hamidfar R., Garban F., Brion J.P., et al. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clinical Infectious Diseases 2009, 48:e9-e15.
8. Martino R., Bretagne S., Einsele H., Maertens J., Ullmann A.J., Parody R., et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clinical Infectious Diseases 2005, 40:67-78.
9. Martino R., Bretagne S., Rovira M., Ullmann A.J., Maertens J., Held T., et al. Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 2000, 25:1111-1114.
10. Meers S., Lagrou K., Theunissen K., Dierickx D., Delforge M., Devos T., et al. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation. Clinical Infectious Diseases 2010, 50:1127-1134.
11. Mele A., Paterson P.J., Prentice H.G., Leoni P., Kibbler C.C. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplantation 2002, 29:691-698.
12. Costa J.M., Pautas C., Ernault P., Foulet F., Cordonnier C., Bretagne S. Real Time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. Journal of Clinical Microbiology 2000, 8:2929-2932.
13. Costa J.M., Munoz C., Krüger D., Martino R., Held T.K., Dardé M.L., et al. Quality control for the diagnosis of Toxoplasma gondii reactivation in SCT patients using PCR assays. Bone Marrow Transplantation 2001, 28:527-528.
14. Guy E.C., Joynson D.H. Potential of the polymerase chain reaction in the diagnosis of active Toxoplasma infection by detection of parasite in blood. The Journal of Infectious Diseases 1995, 172:319-322.
15. Brenier-Pinchart M.P., Garban F., Fricker-Hidalgo H., Richard M.J., Makowski C., Pelloux H. Avoidance of Toxoplasma gondii transmission from a recently infected donor to the recipient of hematopoietic stem cell transplantation. Bone Marrow Transplantation 2005, 35:735-736.
16. Chandrasekar P.H. Real-time polymerase chain reaction for early diagnosis of toxoplasmosis in stem cell transplant recipients: ready for prime time?. Clinical Infectious Diseases 2005, 40:79-81.
17. Garcia B.S., Ocampo S.A., Ladron De Guevara G.C. Toxoplasmosis after antineoplastic therapy in non-Hodgkin lymphoma. Demand of preventive measures. Revista Clínica Española 2002, 202:148-151.
18. Hadem J., Schröder F., Winkler T., Gohrbandt B., Fischer D., Korte T., et al. One day from dyspnea to death-unsuccessful application of extracorporeal membrane oxygenation in toxoplasma myocarditis following bone marrow transplantation. Clinical Research in Cardiology 2006, 95:477-481.
19. Hierl T., Reischl U., Lang P., Hebart H., Stark M., Kyme P., et al. Preliminary evaluation of one conventional nested and two real-time PCR assays for the detection of Toxoplasma gondii in immunocompromised patients. Journal of Medical Microbiology 2004, 53:629-632.
20. Laibe S., Ranque S., Curtillet C., Faraut F., Dumon H., Franck J. Timely diagnosis of disseminated toxoplasmosis by sputum examination. Journal of Clinical Microbiology 2006, 44:646-648.
21. Lee B. Encephalopathy after bone marrow transplantation. The Pediatric Infectious Disease Journal 2005, 24(83-84):94-95.
22. Matsuo Y., Takeishi S., Miyamoto T., Nonami A., Kikushige Y., Kunisaki Y., et al. Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. European Journal of Haematology 2007, 79:317-321.
23. Menotti J., Vilela G., Romand S., Garin Y.J., Ades L., Gluckman E., et al. Comparison of PCR-enzyme-linked immunosorbent assay and Real Time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient. Journal of Clinical Microbiology 2003, 41:5313-5316.
24. Pitchford C.W., Welch D.C. A confused 55-year-old man. Disseminated toxoplasmosis. Archives of Pathology & Laboratory Medicine 2006, 130:567-568.
25. Nakane M., Ohashi K., Tominaga J., Akiyama H., Hiruma K., Sakamaki H. Disseminated toxoplasmosis after CD34+-selected autologous peripheral blood stem cell transplantation. Haematologica 2000, 85:334-335.
26. Ortonne N., Ribaud P., Meignin, Sarfati C., Esperou H., Devergie A., et al. Toxoplasmic pneumonitis leading to fatal acute respiratory distress syndrome after engraftment in three bone marrow transplant recipients. Transplantation 2001, 72:1838-1840.
27. Peacock J.E., Greven C.M., Cruz J.M., Hurd D.D. Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?. Bone Marrow Transplantation 1995, 15:983-987.
28. Straathof C.S., Kortbeek L.M., Roerdink H., Sillevis Smitt P.A., van den Bent M.J. A solitary spinal cord toxoplasma lesion after peripheral stem-cell transplantation. Journal of Neurology 2001, 248:814-815.
29. Yadlapati S., Dorsky D., Remington J.S., Edwards R.L., Feingold J.M., Tutschka P.J., et al. Ocular toxoplasmosis after autologous peripheral-blood stem-cell transplantation. Clinical Infectious Diseases 1997, 25:1255-1256.
30. Slavin M.A., Meyers J.D., Remington J.S., Hackman R.C. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplantation 1994, 13:549-557.
31. Wreghitt T.G., Joynson D.H.M. Toxoplasma infection in immunosuppressed (HIV-negative) patients. Toxoplasmosis 2005, 179-192. Cambridge University Pres, Cambridge. D.H.M. Joynson, T.G. Wreghitt (Eds.).
32. Bretagne S., Costa J.M., Foulet F., Jabot-Lestang L., Baud-Camus F., Cordonnier C. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients. Transplant Infectious Disease 2000, 2:127-132.
33. Edvinsson B., Lundquist J., Ljungman P., Ringdén O., Evengård B. A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation. APMIS 2008, 116:345-351.
34. Joss A.W.L. Diagnosis. Human Toxoplasmosis 1992, 79-118. Oxford University Pres, New York. D.O. Ho-Yen, A.W.L. Joss (Eds.).
35. Balfour A.H., Harford J.P., Goodall M. Use of monoclonal antibodies in an ELISA to detect IgM class antibodies specific for Toxoplasma gondii. Journal of Clinical Pathology 1987, 40:853-857.
36. Payne R.A., Joynson D.H., Balfour A.H., Harford J.P., Fleck D.G., Mythen M., et al. Public Health Laboratory Service enzyme linked immunosorbent assay for detecting Toxoplasma specific IgM antibody. Journal of Clinical Pathology 1987, 40:276-281.
37. Roemer E., Blau I.W., Basara N., Kiehl M.G., Bischoff M., Günzelmann S., et al. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clinical Infectious Diseases 2001, 32:E1-E8.
38. Janitschke K., Held T., Krüiger D., Schwerdtfeger R., Schlier G., Liesenfeld O. Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation. Clinical Laboratory 2003, 49:239-242.
39. Ajzenberg D., Dumètre A., Dardé M.L. Multiplex PCR for typing strains of Toxoplasma gondii. Journal of Clinical Microbiology 2005, 43:1940-1943.
40. Deǧirmenci A., Döskaya M., Caner A., Ciçek C., Korkmaz M., Gürüz Y., et al. Toxoplasma gondii RH Ankara: production of evolving tachyzoites using a novel cell culture method. Experimental Parasitology 2011, 128:1-8.